These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3936261)

  • 41. Hepatic stellate cells and intralobular innervation in human liver cirrhosis.
    Ueno T; Sata M; Sakata R; Torimura T; Sakamoto M; Sugawara H; Tanikawa K
    Hum Pathol; 1997 Aug; 28(8):953-9. PubMed ID: 9269832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoelectron microscopic localization of laminin, type IV collagen, and type III pN-collagen in reticular fibers of human lymph nodes.
    Karttunen T; Sormunen R; Risteli L; Risteli J; Autio-Harmainen H
    J Histochem Cytochem; 1989 Mar; 37(3):279-86. PubMed ID: 2918219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
    Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
    Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and cellular localization of fibrillin-1 in normal and pathological human liver.
    Dubuisson L; Lepreux S; Bioulac-Sage P; Balabaud C; Costa AM; Rosenbaum J; Desmoulière A
    J Hepatol; 2001 Apr; 34(4):514-22. PubMed ID: 11394650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases.
    Morelli A; Vedovelli A; Fiorucci S; Angelini GP; Fini C; Palmerini CA; Floridi A
    Clin Chim Acta; 1985 May; 148(2):87-95. PubMed ID: 3888456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells.
    Milani S; Herbst H; Schuppan D; Hahn EG; Stein H
    Hepatology; 1989 Jul; 10(1):84-92. PubMed ID: 2737606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical markers of hepatic fibrosis.
    Plebani M; Burlina A
    Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity.
    McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ
    Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis.
    Eghbali-Fatourechi G; Sieck GC; Prakash YS; Maercklein P; Gores GJ; Fitzpatrick LA
    Endocrinology; 1996 May; 137(5):1894-903. PubMed ID: 8612529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CCl4 rat model.
    Davis BH; Madri JA
    Am J Pathol; 1987 Jan; 126(1):137-47. PubMed ID: 2433943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic application of specific antiprocollagen sera. II. Analysis of liver biopsies.
    Wick G; Brunner H; Penner E; Timpl R
    Int Arch Allergy Appl Immunol; 1978; 56(4):316-24. PubMed ID: 344227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
    Cantin AM; Boileau R; Bégin R
    Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.
    Castilla A; Prieto J; Fausto N
    N Engl J Med; 1991 Apr; 324(14):933-40. PubMed ID: 1900574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical localization of procollagens. II. Electron microscopic distribution of procollagen I antigenicity in the odontoblasts and predentin of rat incisor teeth by a direct method using peroxidase linked antibodies.
    Karim A; Cournil I; Leblond CP
    J Histochem Cytochem; 1979 Jul; 27(7):1070-83. PubMed ID: 89154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum marker of type III procollagen in patients with idiopathic hemochromatosis and its relationship to hepatic fibrosis.
    Colombo M; Annoni G; Donato MF; Fargion S; Tiribelli C; Dioguardi N
    Am J Clin Pathol; 1983 Oct; 80(4):499-502. PubMed ID: 6624714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY; Chu CM; Sheen IS; Liaw YF
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
    Feng H; Leng X; Zhang Z
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver.
    Raedsch R; Stiehl A; Sieg A; Walker S; Kommerell B
    Gastroenterology; 1983 Dec; 85(6):1265-70. PubMed ID: 6628925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma.
    Tarao K; Hoshino H; Shimizu A; Ohkawa S; Nakamura Y; Harada M; Ito Y; Tamai S; Akaike M; Sugimasa Y
    Jpn J Cancer Res; 1994 Oct; 85(10):1040-4. PubMed ID: 7961106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.